Actively Recruiting
Bispectral-Electroencephalography (EEG) in First Time Hemodialysis
Led by Suez Canal University · Updated on 2026-04-28
20
Participants Needed
2
Research Sites
552 weeks
Total Duration
On this page
Sponsors
S
Suez Canal University
Lead Sponsor
D
Dalian Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The severity of minimal dialysis disequilibrium syndrome (DDS) is currently detected and graded clinically using clinical criteria. Bispectral Index (BIS), an electroencephalographic (EEG) derived parameter is widely used in anesthesia and Critical Care setting to detect effects of anesthetic/hypnotic drugs. The aim of our study was to assess the discriminative power of BIS monitoring to accurately detect DDS.
CONDITIONS
Official Title
Bispectral-Electroencephalography (EEG) in First Time Hemodialysis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- First Time renal Dialysis
You will not qualify if you...
- Use of sedatives, hypnotics, psychotropic drugs
- Presence of neurological disorders affecting mental state such as hepatic encephalopathy, stroke, stupor, or dementia
- History of kidney transplant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Dalian Medical University
Dalian, China
Actively Recruiting
2
Theodor Bilharz Research Institute
Cairo, Egypt, 8046
Actively Recruiting
Research Team
A
Ashraf Dahaba, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here